Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04211246
Other study ID # 2019-12-027
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 7, 2020
Est. completion date March 28, 2022

Study information

Verified date March 2022
Source Kangbuk Samsung Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Excessive oxygen administration is known to cause oxidative stress, and absorption atelectasis. Hyperoxia is very common in general anesthesia settings. Even though there are concerns in using excessive oxygen during general anesthesia, the optimal fraction of inspired oxygen (FiO2) for general anesthesia is not well studied. The oxygen reserve index (ORI) is a parameter which can evaluate partial pressure of oxygen (PaO2) rating from 0 to 1. There are growing evidences in ORI that it might be helpful to reduce hyperoxia in critically ill patients in the intensive care unit, as well as in general anesthesia. The aim of this study is to evaluate efficacy of oxygen reserve index to reduce hyperoxemia in major abdominal surgery.


Recruitment information / eligibility

Status Completed
Enrollment 64
Est. completion date March 28, 2022
Est. primary completion date March 28, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - Patients scheduled for elective major abdominal surgery expected to last more than 2hours. - Patients who are scheduled for invasive arterial cannulation during surgery. Exclusion Criteria: - Abnormal pulmonary function test - Pregnancy - Saturation of oxygen (SpO2) is below 92% in room air

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Titration of fraction of inspired oxygen (FiO2) guided by SpO2
Titration of fraction of inspired oxygen (FiO2) guided by SpO2
Titration of fraction of inspired oxygen (FiO2) guided by ORI and SpO2
Titration of fraction of inspired oxygen (FiO2) guided by ORI and SpO2

Locations

Country Name City State
Korea, Republic of Kangbuk Samsung Hospital Seoul

Sponsors (1)

Lead Sponsor Collaborator
Eunah Cho, MD

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary Pressure of arterial oxygen (PaO2) after 1 hour of surgery. Pressure of arterial oxygen is obtain from arterial blood gas analysis as usual practice. After 1 hour of surgery
Secondary Pressure of arterial oxygen (PaO2) after 2 hours of surgery. Pressure of arterial oxygen is obtain from arterial blood gas analysis as usual practice. After 2 hours of surgery
Secondary Pressure of arterial oxygen (PaO2) after 3 hours of surgery. Pressure of arterial oxygen is obtain from arterial blood gas analysis as usual practice. After 3 hours of surgery
Secondary Minimal and maximal value of PaO2 throughout the surgery Pressure of arterial oxygen is obtain from arterial blood gas analysis as usual practice. 1 hour after the end of surgery
Secondary Fraction of inspired oxygen (FiO2) Fraction of inspired oxygen (FiO2) administered during the surgery 1 hour after the end of surgery
Secondary Oxygen reserve index (ORI) Oxygen reserve idex shown from the monitoring device during the surgery 1 hour after the end of surgery
See also
  Status Clinical Trial Phase
Recruiting NCT04772183 - OxyGap : Comparison Between Different Pulse Oximeter and With the Arterial Blood Gase
Not yet recruiting NCT06102499 - Comparison of Pulse Oximetry (SpO2) With Different Oximeters and Arterial Saturation (SaO2): Oxygap2 Study
Recruiting NCT05912543 - A Titration of Fractional Inspired Oxygen Using Oxygen Reserve Index in Child N/A
Recruiting NCT04198077 - Conservative Versus Conventional Oxygen Administration in Critically Ill Patients Phase 4
Completed NCT05505032 - Oxygen Reserve Index and Prevention of Hyperoxemia Phase 4
Completed NCT04965844 - Closed-loop Oxygen Control for High Flow Nasal Therapy N/A